Lucinity and Facctum Partner for AI-Powered, Real-Time Watchlist Screening and Investigations
October 08, 2024 07:43 ET
|
Lucinity
Lucinity and Facctum Partner for AI-Powered, Real-Time Watchlist Screening and Investigations
The Southport CoLAB Community Lecture Series to Host Fairfield County’s Sneak Peek Screening and Panel Discussion for ‘Hopeville: How to Win the Reading Wars’
March 28, 2024 10:45 ET
|
The Southport School Inc
SOUTHPORT, Conn., March 28, 2024 (GLOBE NEWSWIRE) -- The Southport CoLAB, a resource providing quality education training for professionals, educators, and families to affect positive outcomes for...
High Throughput Screening Market Set to Exceed US$ 92.5 Billion by 2034, Riding on 10.5% CAGR | Reveals FMI Inc.
March 07, 2024 07:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 07, 2024 (GLOBE NEWSWIRE) -- The global high throughput screening market had an estimated valuation of US$ 25.7 billion in 2023 and is expected to reach a size of US$ 92.5 billion...
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
September 18, 2023 05:59 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
August 28, 2023 06:35 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) today announced the addition of Fred Chasalow, Ph.D., to the...
Voyce From One Health Group Wins “Overall Healthcare Product Of The Year” In 2023 Pet Innovation Awards
August 17, 2023 08:00 ET
|
Pet Innovation Awards
LOS ANGELES, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
July 28, 2023 13:24 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), this week was granted a patent for its Patient Home Monitoring...
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
June 26, 2023 06:15 ET
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board...
Inventiva et Echosens lancent une initiative conjointe pour mieux sensibiliser l’opinion à la NASH et faciliter l’accès au dépistage pour les patients à risque
June 08, 2023 02:30 ET
|
INVENTIVA
Daix (France) et Long Island City (New York, Etats-Unis), Paris (France) et Waltham (Etats-Unis), le 8 juin 2023 - Inventiva (Euronext Paris et Nasdaq : IVA) (la « Société »), société...
Inventiva and Echosens launch joint initiative to increase NASH awareness and access to screening for at-risk patients
June 08, 2023 02:30 ET
|
INVENTIVA
Daix (France), Long Island City (New York, United States) / Paris (France) and Waltham (United States), June 8, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage...